MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Surgery Partners Company Profile (NASDAQ:SGRY)

Consensus Ratings for Surgery Partners (NASDAQ:SGRY) (?)
Ratings Breakdown: 2 Hold Rating(s), 5 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.88)
Consensus Price Target: $23.00 (68.62% upside)

Analysts' Ratings History for Surgery Partners (NASDAQ:SGRY)
Show:
DateFirmActionRatingPrice TargetActions
5/6/2016Morgan StanleyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016Goldman SachsLower Price Target$23.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016Citigroup Inc.Lower Price TargetBuy$25.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016RBC CapitalLower Price TargetOutperform$22.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2015Stifel NicolausInitiated CoverageBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015Raymond JamesInitiated CoverageStrong-Buy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015Bank of AmericaInitiated CoverageBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015Jefferies GroupInitiated CoverageBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha